India Share Brokers | Equity Trading India | Derivative Trading in India | Share Brokers in India

Markets Navigation

Company Info.

Krebs Biochemicals & Industries Ltd.

Income Statement - Standalone

Market Cap.(`)	243.20 Cr.	P/BV	-2.04	Book Value (`)	-55.29
52 Week High/Low ( ` )	129/60	FV/ML	10/1	P/E(X)	0.00
Book Closure	27/09/2023	EPS (`)	0.00	Div Yield (%)	0.00

(` in Crs.)

You can view the Standalone Income Statement for the last 5 years.

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	50.42	26.64	52.94	38.61	23.58
Other Operating Revenues	0.00	25.50	6.76	15.09	9.83
Total Operating Revenues	50.42	52.13	59.70	53.70	33.41

Other Income	0.45	0.62	1.16	0.62	0.37
Total Revenue	50.87	52.75	60.86	54.32	33.78

EXPENSES
Cost Of Materials Consumed	5.43	15.36	46.18	25.62	19.18
Purchase Of Stock-In Trade	0.09	4.44	0.00	0.00	0.00
Operating And Direct Expenses	0.00	0.00	33.06	26.28	17.05
Changes In Inventories Of FG,WIP And Stock-In Trade	1.07	5.87	-5.54	0.32	-3.32
Employee Benefit Expenses	16.47	15.84	15.30	15.83	15.08
Finance Costs	4.69	2.97	5.39	6.28	5.93
Depreciation And Amortisation Expenses	6.77	6.56	6.30	5.12	4.68
Other Expenses	36.08	26.39	4.70	3.22	4.05
Total Expenses	70.60	77.45	105.39	82.68	62.65

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	-19.73	-24.69	-44.53	-28.36	-28.87

Profit/Loss Before Tax	-19.73	-24.69	-44.53	-28.36	-28.87

Tax Expenses-Continued Operations
Profit/Loss After Tax And Before ExtraOrdinary Items	-19.73	-24.69	-44.53	-28.36	-28.87

Profit/Loss From Continuing Operations	-19.73	-24.69	-44.53	-28.36	-28.87

Profit/Loss For The Period	-19.73	-24.69	-44.53	-28.36	-28.87

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	-9.16	-11.30	-20.81	-14.53	-16.75
Diluted EPS (Rs.)	-9.16	-11.30	-20.81	-14.53	-17.90

Krebs Biochemicals & Industries Ltd.

Balance Sheet - Standalone

Market Cap.(`)	243.20 Cr.	P/BV	-2.04	Book Value (`)	-55.29
52 Week High/Low ( ` )	129/60	FV/ML	10/1	P/E(X)	0.00
Book Closure	27/09/2023	EPS (`)	0.00	Div Yield (%)	0.00

(` in Crs.)

You can view the Standalone Balance Sheet for the last 5 years.

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	215.60	215.60	215.60	196.20	180.00

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	21.56	21.56	21.56	19.62	18.00
Preference Share Capital	130.00	130.00	130.00	0.00	0.00
Total Share Capital	151.56	151.56	151.56	19.62	18.00

Reserves and Surplus	-140.78	-121.02	-96.65	-66.52	-50.65
Total Reserves and Surplus	-140.78	-121.02	-96.65	-66.52	-50.65
Money Received Against Share Warrants	0.00	0.00	0.00	4.17	7.65
Total Shareholders Funds	10.78	30.54	54.91	-42.73	-25.00

NON-CURRENT LIABILITIES
Long Term Borrowings	53.50	43.25	2.93	100.55	65.51
Other Long Term Liabilities	51.56	51.79	53.60	52.71	49.69
Long Term Provisions	0.49	0.31	0.30	0.50	0.47
Total Non-Current Liabilities	105.56	95.34	56.83	153.76	115.66

CURRENT LIABILITIES
Short Term Borrowings	9.93	9.99	9.99	0.00	0.00
Trade Payables	18.97	15.28	37.91	20.78	22.65
Other Current Liabilities	32.32	23.09	29.58	26.59	19.65
Short Term Provisions	0.62	0.75	0.59	0.82	0.84
Total Current Liabilities	61.83	49.10	78.06	48.19	43.13

Total Capital And Liabilities	178.17	174.98	189.81	159.22	133.80

ASSETS
NON-CURRENT ASSETS
Tangible Assets	149.30	146.47	137.69	116.26	103.37
Intangible Assets	0.66	0.84	1.02	1.66	1.92
Capital Work-In-Progress	0.16	2.24	6.53	10.09	2.35
Intangible Assets Under Development	1.85	1.85	1.85	1.85	1.85
Fixed Assets	151.96	151.40	147.09	129.86	109.48
Other Non-Current Assets	8.77	7.52	7.23	7.94	5.46
Total Non-Current Assets	160.73	158.92	154.31	137.80	114.94


CURRENT ASSETS
Inventories	9.80	11.95	25.56	16.60	15.00
Trade Receivables	1.90	0.53	0.88	0.30	0.20
Cash And Cash Equivalents	0.14	0.09	0.10	0.71	0.17
OtherCurrentAssets	5.61	3.50	8.95	3.81	3.49
Total Current Assets	17.44	16.06	35.49	21.42	18.86

Total Assets	178.17	174.98	189.81	159.22	133.80

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	4.36	5.63	5.55	5.53	4.84

Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. | | ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. | "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors" | ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600 | For any Grievance mail to : [email protected] | For any DP Grievance mail to : [email protected]. | Grievance with SEBI : https://scores.gov.in/scores/Welcome.html

Share Wealth

Krebs Biochemicals & Industries Ltd.

Income Statement - Standalone

Krebs Biochemicals & Industries Ltd.

Balance Sheet - Standalone